Recommendations for preclinical research in hemorrhagic transformation - Wikidata - awgldk - TriplyDB

Recommendations for preclinical research in hemorrhagic transformation

Recommendations for preclinical research in hemorrhagic transformation

http://www.wikidata.org/entity/Q27024324

about

Hyperbaric oxygen preconditioning attenuates hemorrhagic transformation through increasing PPARγ in hyperglycemic MCAO rats.A cost-effective rabbit embolic stroke bioassay: insight into the development of acute ischemic stroke therapy Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now.Hemorrhagic transformation after ischemic stroke in animals and humans Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia.One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke.Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO--MMP-9 Pathway.Early Increased Bradykinin 1 Receptor Contributes to Hemorrhagic Transformation After Ischemic Stroke in Type 1 Diabetic Rats.Protective Effects of Autologous Bone Marrow Mononuclear Cells After Administering t-PA in an Embolic Stroke Model.Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia.

P2860

Q35137691-90FC596B-B51C-436D-BFC1-719C0C347380 Q35175537-02419B5C-0EBD-40EB-B66B-89E7E61FA1F2 Q37420266-0F14BA0C-E5B2-4B88-9E47-501E1407F9B8 Q37559355-B94F7F4B-133D-4140-840B-BCB590FCA7A5 Q37587747-9251F489-41FB-4014-A265-416C27257F53 Q37668019-1612F7A4-8A9A-408A-A2C5-59D18F5A0816 Q47897171-FAB117A5-1498-4AE0-B647-008FB6895707 Q48097304-DA9E29D7-AD6D-47A0-99AA-57BB61CB15C4 Q48142151-CDDE077B-E461-4B01-B1E3-1071CA4E5E1F Q50224206-C0736EB0-A2AF-49A7-BD23-3020706787FA

P2860

Recommendations for preclinical research in hemorrhagic transformation

http://www.wikidata.org/entity/Q27024324

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Recommendations for preclinical research in hemorrhagic transformation

@ast

Recommendations for preclinical research in hemorrhagic transformation

@en

Recommendations for preclinical research in hemorrhagic transformation

@nl

type

label

Recommendations for preclinical research in hemorrhagic transformation

@ast

Recommendations for preclinical research in hemorrhagic transformation

@en

Recommendations for preclinical research in hemorrhagic transformation

@nl

prefLabel

Recommendations for preclinical research in hemorrhagic transformation

@ast

Recommendations for preclinical research in hemorrhagic transformation

@en

Recommendations for preclinical research in hemorrhagic transformation

@nl

P1433

Q27024324-34E64B47-27F7-4711-8D32-42BD7AEDE555

P1476

Q27024324-0A513D03-379A-4530-9879-4FA618556141

P2093

Q27024324-0C43F3E2-EBFC-4AEE-9831-1D8C11B1F121

Q27024324-5E6CFAC3-1F1E-418D-B1B0-D21BF285C1B5

Q27024324-8936DDB1-3895-4B47-9D12-DC34F1F716A2

Q27024324-FE6E60C3-F0C2-4E7B-A854-19702ACC87DE

P2860

Q27024324-01EE4520-F6A6-417B-B70B-6A985A0D352D

Q27024324-06403514-80F5-4AA1-89EE-AD75C549695D

Q27024324-080757F6-A66B-4FB9-8D58-0FFC76F10DA9

Q27024324-08C4C0B5-66C3-4B24-B8DD-057195B7363F

Q27024324-1A9D5D38-73E4-4C9C-A079-1AF941EE0072

Q27024324-1D429CED-E64B-4B8A-A62E-93B57689DDA2

Q27024324-1DD6A98A-1D9C-432A-A691-FAC5F1059539

Q27024324-23AF153F-D006-4641-BF71-5C37E5AB0546

Q27024324-2EEF3B8D-BA17-416B-8574-F962A4242F7F

Q27024324-309A1191-4925-47C6-9A8C-8B1204D5DD49

P2888

Q27024324-EEA68C23-5DFE-46C7-8BC4-DE363A4706B1

P304

Q27024324-41885BA3-5CE4-408A-8135-DAE8708FBE71

P31

Q27024324-C9F5C609-72D1-41F1-A841-177F5706A493

P356

Q27024324-9EA745AF-E743-47FB-A8B9-864574652412

P407

Q27024324-8233B3B0-6D3C-4D70-A779-98F7878610CB

P433

Q27024324-04568349-5623-4278-B245-4CF7B57583CC

P478

Q27024324-0F18FD9F-8333-4BD8-BBC2-02803E87AF67

P50

Q27024324-B352A86B-349C-4D52-85CE-6D73AFA339F0

P577

Q27024324-6390A7A5-809B-4C58-8231-C9C16F7AD826

P6179

Q27024324-4836A226-D990-47EC-B550-BC3240BE1538

P698

Q27024324-443DFD1A-3AD5-4881-BC97-2644B72BF487

P932

Q27024324-654D2BFE-C9E4-4AE6-A793-498B075E490B

P356

S12975-012-0222-5

P1433

Translational stroke research

P1476

Recommendations for preclinical research in hemorrhagic transformation

@en

P2093

Adviye Ergul

http://www.w3.org/2001/XMLSchema#string

David S Liebeskind

http://www.w3.org/2001/XMLSchema#string

Susan C Fagan

http://www.w3.org/2001/XMLSchema#string

Tauheed Ishrat

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphodiesterase-III inhibitor prevents hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Tissue plasminogen activator for acute ischemic stroke

Hemorrhagic transformation after fibrinolysis with tissue plasminogen activator: evaluation of role of hypertension with rat thromboembolic stroke model.

Thrombolysis with reteplase, an unglycosylated plasminogen activator variant, in experimental embolic stroke.

Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes.

Translational stroke research using a rabbit embolic stroke model: a correlative analysis hypothesis for novel therapy development

Animal models of ischemic stroke. Part two: modeling cerebral ischemia.

Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia

Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling

P2888

s12975-012-0222-5

P304

322-327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12975-012-0222-5

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Paul A. Lapchak

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1023932842

http://www.w3.org/2001/XMLSchema#string

P698

23730351

http://www.w3.org/2001/XMLSchema#string

P932

3667740

http://www.w3.org/2001/XMLSchema#string